
Read More
20% Returns in 1 Month: This Piramal Group Pharma Stock Reports 17% Revenue...
Piramal Pharma reported healthy Q1 FY27 growth across all three business segments, with strong EBITD...

Piramal Pharma reported healthy Q1 FY27 growth across all three business segments, with strong EBITD...